When a distributor introduces a dermocosmetic line to pharmacists and dermatologists, documented tolerability is one of the most persuasive arguments available. In the medical channel, the professionals who recommend a product are putting their own credibility on the line — and they reward brands that minimise the risk of reactions and complaints.
Tolerability as a commercial advantage
A range engineered for sensitive and reactive skin, with patch-test and dermatological-control data behind it, is easier to detail and easier to recommend. Lower irritation potential means fewer returns, fewer complaints and higher satisfaction — all of which protect the distributor’s reputation with its accounts and reduce after-sales friction.
Equipping your sales team
Selling into the medical channel is a scientific conversation. Sales representatives who can point to a clear tolerability profile, controlled ingredient selection and transparent safety data hold credible discussions with pharmacists and prescribers. This evidence base shortens the trust-building cycle and supports premium positioning.
The Galenia approach
Galenia Skincare formulations are developed alongside dermatologists and pharmacists, engineered for high tolerability and backed by transparent safety and efficacy documentation. For the distributor, this is more than a formulation principle — it is a ready-made sales argument and a safeguard for long-term account relationships in the medical channel.
